Tag Archive for: Unnatural Products Inc

Syntethic macrocyclic peptid compared with a typical small molecule drugUnnatural Products Inc
Partnership

Argenx and Unnatural Products ink US$1.5bn macrocycle deal

California oral macrocyclic peptide specialist Unnatural Products, Inc. and Dutch-Belgian Argenx SE have formed a multi-target research collaboration aimed at developing oral macrocyclic peptide drugs with UNP’s synthetic macrocycle platform.

Read more